News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Cellectis announced a strategic shift to become an in vivo gene editing company.
  • The company will advance HEAL‑101 and HEAL‑201 targeting severe hypertriglyceridemia and hypercholesterolemia.
  • Cellectis plans Phase 1 starts and preliminary data from those programs by 2027–2028.
  • Cellectis is exiting development of lasme‑cel and eti‑cel.
  • Management says the restructuring should extend Cellectis's cash runway into H2 2028.
  • Cellectis will reallocate resources to its gene‑editing assets and existing cell‑therapy partnerships.

Latest Articles

Jefferson Capital Reports Second Quarter 2026 Results

Jefferson Capital Reports Second Quarter 2026 Results

Jefferson Capital, Inc., a purchaser and manager of consumer receivables, announced its second quarter 2026 results highlighting an 18% increase in collections to $300.9 million and a 21% rise in deployments to $152.2 million. Estimated Remaining Collections grew 18% to $3.4 billion. The company reported pre-tax income of $53.3 million and net inco…

Eton Pharmaceuticals Reports Second Quarter 2026 Financial Results

Eton Pharmaceuticals Reports Second Quarter 2026 Financial Results

Eton Pharmaceuticals reported strong Q2 2026 results with record product sales of $37.6 million, reflecting 99% growth year-over-year. The company achieved positive GAAP and non-GAAP earnings per share, expanded its rare disease portfolio with the licensing of the late-stage product ASN-001, and raised full-year revenue guidance to exceed $145 mill…

PEDEVCO Reports Second Quarter 2026 Results

PEDEVCO Reports Second Quarter 2026 Results

PEDEVCO Corp. reported a substantial increase in revenue and net income for Q2 2026, driven by a 348% increase in production and higher oil prices following the October 2025 merger that expanded its asset base. Adjusted EBITDA rose 516% to $18.7 million, reflecting improved operational scale and financial performance. The company initiated an enhan…

4DMT Reports Second Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones

4DMT Reports Second Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones

4D Molecular Therapeutics reported strong second quarter 2026 results including completion of enrollment for its 4FRONT-2 Phase 3 trial for wet AMD, and expects topline data from both 4FRONT-1 and 4FRONT-2 trials in 2027. The company also presented positive 2-year Phase 2b data for 4D-150 and plans to initiate a Phase 3 trial for diabetic macular e…

Roadzen Delivers Best Quarter in Company History with Record Q1 FY2027 Revenue of $16.2 Million, Up 49% Year-Over-Year

Roadzen Delivers Best Quarter in Company History with Record Q1 FY2027 Revenue of $16.2 Million, Up 49% Year-Over-Year

Roadzen Inc. announced its best quarter ever with Q1 FY2027 revenue of $16.2 million, up 49% year-over-year, driven by strong adoption of its AI platform in insurance and mobility sectors. The company improved adjusted EBITDA loss by 73% and signed a definitive agreement to acquire a European MGA specializing in short-term car rental insurance, exp…

Quantum-Si Reports Second Quarter 2026 Financial Results and Provides Proteus™ Development Update

Quantum-Si Reports Second Quarter 2026 Financial Results and Provides Proteus™ Development Update

Quantum-Si Incorporated announced its Q2 2026 financial results, highlighting a delay in the commercial launch of its Proteus protein sequencing platform to Q2 2027 for additional development and manufacturing readiness. The company recorded $344 thousand in revenue during the Proteus transition period, implemented a 20% workforce reduction to alig…

CapsoVision Reports Second Quarter 2026 Financial Results

CapsoVision Reports Second Quarter 2026 Financial Results

CapsoVision, a medical technology company specializing in AI-enabled capsule endoscopy, reported Q2 2026 revenue of $3.6 million, up 10% year-over-year. The company launched its AI Highlights™ product in the EU and expects FDA clearance and U.S. launch by Q3 end. Product adoption across hospitals and GI networks is expanding, and the CapsoCam Colon…

MacroGenics Reports Second Quarter 2026 Financial Results, Streamlined Operating Model and Strengthened Financial Position

MacroGenics Reports Second Quarter 2026 Financial Results, Streamlined Operating Model and Strengthened Financial Position

MacroGenics announced solid second quarter 2026 financial results highlighted by $32.8 million in revenue driven by milestone payments, net income of $19.5 million including discontinued operations, and a strengthened cash position of $327 million after the sale of its manufacturing operations. The company is transitioning to an outsourced manufact…

MDB Capital Holdings Provides Second Quarter 2026 Update

MDB Capital Holdings Provides Second Quarter 2026 Update

MDB Capital Holdings announced its Q2 2026 operational and financial update, showcasing successful underwriting of IPOs including Buda Juice, Ticketplus, and eXoZymes. The company expanded its pipeline of disruptive technology ventures, progressed strategic partnerships to enhance distribution, and initiated the spin-out of its AI-driven PatentVest…

Glass House Brands Reports Second Quarter 2026 Financial Results

Glass House Brands Reports Second Quarter 2026 Financial Results

Glass House Brands Inc. reported its second quarter 2026 financial results featuring record cannabis biomass production of 246,000 pounds at a cost of $122 per pound, improved from the prior quarter. The company completed the deconsolidation of its dual-use retail business, focusing on a medically licensed, Schedule III compliant model. Revenue was…

Midera Food Processing Reports Second Quarter 2026 Results in First Report as an Independent Public Company

Midera Food Processing Reports Second Quarter 2026 Results in First Report as an Independent Public Company

Midera Food Processing, newly independent from The Middleby Corporation as of July 2026, reported a 13.2% increase in net sales to $245 million in Q2 2026 alongside a 16% increase in orders and a record backlog of $446 million. Despite a decline in net earnings compared to the prior year, the company posted a 10.6% increase in estimated standalone …

New Survey of 255 School-Based Therapists Reveals Rising Caseloads and Hidden Workload Threatening Student Access to Federally Mandated Services

New Survey of 255 School-Based Therapists Reveals Rising Caseloads and Hidden Workload Threatening Student Access to Federally Mandated Services

Kelly Pediatric Therapy, a division of Kelly Education, released a white paper based on a survey of 255 school-based therapists highlighting rising caseloads, extensive administrative duties, and growing complexity of student needs, which threaten therapist sustainability and student access to federally mandated pediatric therapy services. The find…

Canada Nickel: A Volatile Long with Squeeze Potential — Proceed, But Only If You Respect the Balance Sheet

Canada Nickel: A Volatile Long with Squeeze Potential — Proceed, But Only If You Respect the Balance Sheet

CNIKF trades at $1.10 with constructive momentum and an outsized short position (3.94M shares, 53.3 days to cover on 07/31/2026). That combination can spark sharp rallies if a financing or positive drill update lands — but the company’s OTC status, lack of public market cap/shares disclosure, and signs of thin liquidity mean financing will probably…

Argentina's Inflation Edges Up in July as Services Lead Price Gains

Argentina's Inflation Edges Up in July as Services Lead Price Gains

Argentina's consumer prices increased 2.1% in July, slightly above June's 1.9% and marginally higher than analyst expectations. Annual inflation rose to 33.8% from 33.5%. Service sectors tied to winter holidays, including recreation, restaurants and hotels, accounted for the largest upward pressure while clothing and footwear recorded a minor decli…

Tether Secures First Full Independent Audit From KPMG US

Tether Secures First Full Independent Audit From KPMG US

Tether announced it has obtained its first full independent audit of financial statements from KPMG US. The El Salvador-based stablecoin issuer said KPMG issued an unqualified opinion, but the audit report itself has not been made public. The firm had previously relied on quarterly reserve attestations amid difficulties obtaining audits from major …

Ashland: Ancora Momentum Makes This a Tactical Long

Ashland: Ancora Momentum Makes This a Tactical Long

Ashland (ASH) has been in the activist spotlight since Ancora’s presentation and the board’s public engagement. The stock is trading well above its 50-day average and shows bullish technical momentum while fundamentals - including $237M in free cash flow and a $0.42 quarterly dividend - give the company optionality on buybacks, divestitures or acce…